-
Signature
-
/s/ Nathaniel S. Gardiner as attorney-in-fact
-
Stock symbol
-
ENTA
-
Transactions as of
-
Mar 1, 2022
-
Transactions value $
-
-$984,485
-
Form type
-
4
-
Date filed
-
3/3/2022, 05:02 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ENTA |
Common Stock |
Options Exercise |
$1.06M |
+24.3K |
+69.58% |
$43.46 |
59.3K |
Mar 1, 2022 |
Direct |
|
transaction |
ENTA |
Common Stock |
Sale |
-$1.7M |
-24.2K |
-40.86% |
$70.26 |
35.1K |
Mar 1, 2022 |
Direct |
F1, F2 |
transaction |
ENTA |
Common Stock |
Sale |
-$7.11K |
-100 |
-0.29% |
$71.06 |
35K |
Mar 1, 2022 |
Direct |
F1 |
transaction |
ENTA |
Common Stock |
Options Exercise |
$542K |
+12.5K |
+35.68% |
$43.46 |
47.5K |
Mar 2, 2022 |
Direct |
|
transaction |
ENTA |
Common Stock |
Sale |
-$875K |
-12.5K |
-26.3% |
$70.07 |
35K |
Mar 2, 2022 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ENTA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-24.3K |
-66.1% |
$0.00 |
12.5K |
Mar 1, 2022 |
Common Stock |
24.3K |
$43.46 |
Direct |
F4 |
transaction |
ENTA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-12.5K |
-100% |
$0.00* |
0 |
Mar 2, 2022 |
Common Stock |
12.5K |
$43.46 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
The reporting person undertakes to provide to Enanta Pharmaceuticals, Inc., any security holder of Enanta Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 above.